top of page

Leor Lab

IMG-20190416-WA0001.jpg
Yeshai Schary, PhD student

 

E-mail:  yeshaischary@mail.tau.ac.il

Phone: +972-3-530-8409

​

Yeshai is a PhD student. His research focuses on CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy. He aims to to provide a new strategy to enhance MSC-based cell therapy to improve cardiac remodeling and function in patients who suffer from heart failure.

Publications

 

  1. Schary Y, Naftali-Shani N, and Leor J. CRISPR/Cas9-Based Knockout of the TLR4 gene Enhances Secretion of Extracellular Vesicles With Anti-Inflammatory Properties From Human Cardiac Mesenchymal Stromal Cells. Circulation Research 125.Suppl_1 (2019): A719-A719.

  2. Rotem I, Schary Y, Teper O, Konfino T and Leor, J. (2019). P314 Osteopontin stimulates cell cycle in neonatal cardiomyocytes. European Heart Journal. 40. 10.1093/eurheartj/ehz747.0149

  3. Cohn Yakubovich D, Sheyn D, Bez M, Schary Y, Yalon E, Sirhan S, Amira M, Yaya A, De Mel S, Da X, Ben-David S, Tawackoli W, J. Ley E, Gazit D, Gazit Z and Pelled G. Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures. Stem cell research & therapy. 2017 Dec;8(1):51.

  4. Cohn Yakubovich D, Eliav U, Yalon E, Schary Y, Sheyn D, Cook-Wiens G, Sun S, McKenna CE, Lev S, Binshtok AM, G. . Bone. 2017 Apr 1;97:192-200.

Jonathan Leor Lab of Cardiovascular Research

 

Neufeld Cardiac Research Institute, Tel Aviv University.

Tamman Cardiovascular  Research Institute, Sheba Medical Center.
Sheba Center for Regenerative Medicine, Stem Cells, and Tissue Engineering.

Tel-Hashomer, 52621, Israel,

 

Tel: 972-3-530-2614

Email:  leorj@post.tau.ac.il

 

bottom of page